Proximity Detection Systems (PDS) are leveraging rapidly advancing technology to enhance functionality, according to Anton Lourens, CEO of .

PDS Biotechnology has commenced the randomised, multi-centre Phase III clinical trial, VERSATILE-003, to assess the efficacy ...

Delhi Cabinet Minister Manjinder Singh Sirsa reviewed the Delhi Food and Supplies Department to enhance the Public ...

The current watch is what’s called a PDS tornado watch. PDS stands for “particularly dangerous situation.” It will be in effect until 8 p.m. Saturday. The Storm Prediction Center said “the ...

HC Wainwright reiterated their buy rating on shares of PDS Biotechnology (NASDAQ:PDSB – Free Report) in a report issued on Thursday,Benzinga reports. The firm currently has a $21.00 price target on ...

In 2021, Converge Technology Solutions acquired mobility and application specialist OPIN Digital Inc.; data analytics firm ... today of Delaware-based PDS Holding Company includes Paragon ...

PDS Biotechnology (NASDAQ ... InvestorPlace Earnings is a project that leverages data from TradeSmith to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key ...

We are thrilled to share that the first trial site has been initiated and activation of additional clinical sites continues,” said Frank Bedu-Addo, PhD, President and Chief Executive Officer of PDS ...

PDS Biotechnology (PDSB) announced that the U.S. Food and Drug Administration has cleared its Investigational New Drug application filed in ...

Detailed price information for Pds Biotechnology Corp (PDSB-Q) from The Globe and Mail including charting and trades.

HC Wainwright restated their buy rating on shares of PDS Biotechnology (NASDAQ:PDSB – Free Report) in a research note published on Friday,Benzinga reports. They currently have a $21.00 target price on ...